Mai Tuyet Pho to Cost-Benefit Analysis
This is a "connection" page, showing publications Mai Tuyet Pho has written about Cost-Benefit Analysis.
Connection Strength
0.416
-
The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection. Ann Intern Med. 2015 May 05; 162(9):619-29.
Score: 0.109
-
Optimizing tuberculosis case detection through a novel diagnostic device placement model: the case of Uganda. PLoS One. 2015; 10(4):e0122574.
Score: 0.108
-
The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis. PLoS One. 2012; 7(4):e36001.
Score: 0.088
-
Health economic analyses of the justice community opioid innovation network (JCOIN). J Subst Abuse Treat. 2021 09; 128:108262.
Score: 0.040
-
Comparison of effectiveness and cost for different HIV screening strategies implemented at large urban medical centre in the United States. J Int AIDS Soc. 2020 10; 23(10):e25554.
Score: 0.040
-
Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis. PLoS Negl Trop Dis. 2017 04; 11(4):e0005459.
Score: 0.031